| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ABL SH3 mutant inhibits BCR-ABL activity and increases imatinib sensitivity by targeting RIN1 protein in CML cell
|
Liu, Xin
|
|
2015
|
369 |
1 |
p. 222-228
7 p.
|
artikel
|
| 2 |
Aldehyde dehydrogenases and cancer stem cells
|
Xu, Xia
|
|
2015
|
369 |
1 |
p. 50-57
8 p.
|
artikel
|
| 3 |
Androgen receptor inhibits epithelial–mesenchymal transition, migration, and invasion of PC-3 prostate cancer cells
|
Huo, Chieh
|
|
2015
|
369 |
1 |
p. 103-111
9 p.
|
artikel
|
| 4 |
Circulating miRNAs revealed as surrogate molecular signatures for the early detection of breast cancer
|
Mishra, Sanjay
|
|
2015
|
369 |
1 |
p. 67-75
9 p.
|
artikel
|
| 5 |
Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas
|
Li, Yi
|
|
2015
|
369 |
1 |
p. 86-96
11 p.
|
artikel
|
| 6 |
Corrigendum to “Fhit loss in lung preneoplasia: Relation to DNA damage response checkpoint activation” [Cancer Lett. 291 (2) (2010) 230–236]
|
Cirombella, Roberto
|
|
2015
|
369 |
1 |
p. 259-
1 p.
|
artikel
|
| 7 |
Corrigendum to “Induction of hyaluronan production by oncogenic KSHV and the contribution to viral pathogenesis in AIDS patients” [Cancer Lett. 2015 Jul 1;362(2):158–66]
|
Dai, Lu
|
|
2015
|
369 |
1 |
p. 260-
1 p.
|
artikel
|
| 8 |
Dichotomous role of protein kinase A type I (PKAI) in the tumor microenvironment: A potential target for ‘two-in-one’ cancer chemoimmunotherapeutics
|
Hussain, Muzammal
|
|
2015
|
369 |
1 |
p. 9-19
11 p.
|
artikel
|
| 9 |
Distribution and risk of the second discordant primary cancers combined after a specific first primary cancer in German and Swedish cancer registries
|
Chen, Tianhui
|
|
2015
|
369 |
1 |
p. 152-166
15 p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
2015
|
369 |
1 |
p. ii-
1 p.
|
artikel
|
| 11 |
Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma
|
Kim, Sang-Soo
|
|
2015
|
369 |
1 |
p. 250-258
9 p.
|
artikel
|
| 12 |
Enhanced anti-colon cancer immune responses with modified eEF2-derived peptides
|
Sun, Weihong
|
|
2015
|
369 |
1 |
p. 112-123
12 p.
|
artikel
|
| 13 |
Epigenetic silencing of Kruppel like factor-3 increases expression of pro-metastatic miR-182
|
Sachdeva, Mohit
|
|
2015
|
369 |
1 |
p. 202-211
10 p.
|
artikel
|
| 14 |
Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic target for gastric cancer
|
Liu, Yanfang
|
|
2015
|
369 |
1 |
p. 58-66
9 p.
|
artikel
|
| 15 |
Integrated proteo-genomic approach for early diagnosis and prognosis of cancer
|
Shukla, Hem D.
|
|
2015
|
369 |
1 |
p. 28-36
9 p.
|
artikel
|
| 16 |
MART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potential
|
Chiang, Kun-Chun
|
|
2015
|
369 |
1 |
p. 76-85
10 p.
|
artikel
|
| 17 |
Notch signaling: An emerging therapeutic target for cancer treatment
|
Yuan, Xun
|
|
2015
|
369 |
1 |
p. 20-27
8 p.
|
artikel
|
| 18 |
NRF2/miR-140 signaling confers radioprotection to human lung fibroblasts
|
Duru, Nadire
|
|
2015
|
369 |
1 |
p. 184-191
8 p.
|
artikel
|
| 19 |
Phase I trial of multidrug resistance-associated protein 3-derived peptide in patients with hepatocellular carcinoma
|
Mizukoshi, Eishiro
|
|
2015
|
369 |
1 |
p. 242-249
8 p.
|
artikel
|
| 20 |
Post-transplant lymphoproliferative disorders: From epidemiology to pathogenesis-driven treatment
|
Petrara, Maria Raffaella
|
|
2015
|
369 |
1 |
p. 37-44
8 p.
|
artikel
|
| 21 |
Pro-chemotherapeutic effects of antibody against extracellular domain of claudin-4 in bladder cancer
|
Kuwada, Masaomi
|
|
2015
|
369 |
1 |
p. 212-221
10 p.
|
artikel
|
| 22 |
Publisher's Note
|
|
|
2015
|
369 |
1 |
p. v-
1 p.
|
artikel
|
| 23 |
Radiosensitization of metformin in pancreatic cancer cells via abrogating the G2 checkpoint and inhibiting DNA damage repair
|
Wang, Zheng
|
|
2015
|
369 |
1 |
p. 192-201
10 p.
|
artikel
|
| 24 |
Radon exposure and oropharyngeal cancer risk
|
Salgado-Espinosa, Tania
|
|
2015
|
369 |
1 |
p. 45-49
5 p.
|
artikel
|
| 25 |
Reprogramming cancer cells: A novel approach for cancer therapy or a tool for disease-modeling?
|
Yilmazer, Açelya
|
|
2015
|
369 |
1 |
p. 1-8
8 p.
|
artikel
|
| 26 |
Retro-inverso bradykinin opens the door of blood–brain tumor barrier for nanocarriers in glioma treatment
|
Xie, Zuoxu
|
|
2015
|
369 |
1 |
p. 144-151
8 p.
|
artikel
|
| 27 |
Sonic hedgehog-glioma associated oncogene homolog 1 signaling enhances drug resistance in CD44+/Musashi-1+ gastric cancer stem cells
|
Xu, Min
|
|
2015
|
369 |
1 |
p. 124-133
10 p.
|
artikel
|
| 28 |
Stabilization of MCRS1 by BAP1 prevents chromosome instability in renal cell carcinoma
|
Peng, Jingtao
|
|
2015
|
369 |
1 |
p. 167-174
8 p.
|
artikel
|
| 29 |
Suppression of the GTPase-activating protein RGS10 increases Rheb-GTP and mTOR signaling in ovarian cancer cells
|
Altman, Molly K.
|
|
2015
|
369 |
1 |
p. 175-183
9 p.
|
artikel
|
| 30 |
Synergistic effects of metformin in combination with EGFR-TKI in the treatment of patients with advanced non-small cell lung cancer and type 2 diabetes
|
Chen, Hengyi
|
|
2015
|
369 |
1 |
p. 97-102
6 p.
|
artikel
|
| 31 |
The molecular signature of AML mesenchymal stromal cells reveals candidate genes related to the leukemogenic process
|
Binato, Renata
|
|
2015
|
369 |
1 |
p. 134-143
10 p.
|
artikel
|
| 32 |
The vascular disrupting activity of OXi8006 in endothelial cells and its phosphate prodrug OXi8007 in breast tumor xenografts
|
Strecker, Tracy E.
|
|
2015
|
369 |
1 |
p. 229-241
13 p.
|
artikel
|
Tijdschrift beschrijving